Treatment of coronary heart disease: Chronic stable angina pectoris (angina of effort).
Treatment of hypertension: Treatment of 6321 hypertensive patients with at least one additional risk factor followed over 3 to 4.8 years in a multi-national, randomised, double-blind, prospective study.
Nifedipine (Adalat LA) was shown to reduce cardiovascular and cerebrovascular events to a comparable degree as a standard diuretic combination (see Pharmacology: Pharmacodynamics under Actions).